Free Republic

The ‘Modern Family’ alum tells PEOPLE that he was initially "embarrassed" about his type 2 diabetes and kept his diagnosis a secret from friends and family Eric Stonestreet used to think his health was “fairly good.” He struggled to lose weight like many people, but felt fine overall. “I was just trying to maintain as healthy a lifestyle as I could without doing a tremendous amount about it,” he tells PEOPLE. But in 2009, just as he landed his beloved role as Cameron Tucker on Modern Family, Stonestreet was diagnosed with type 2 diabetes. “It was like this crazy happy...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical research. In the new analysis of data from the SUMMIT trial, researchers focused on patients with obesity, chronic kidney disease and HFpEF. HFpEF occurs when the heart muscle cannot enlarge sufficiently to accommodate the blood it receives, causing pressure in the heart to become elevated. Chronic kidney disease occurs when the kidneys do not filter waste from the blood as they should, leading to a buildup of toxins. Tirzepatide...

Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.Ozempic, Mounjaro, and other glucagon-like peptide-1 medications, otherwise known as GLP-1s, are changing how Americans shop for groceries. In early January, Food & Wine published a story about how food companies are releasing all-new products or reimagining the marketing of old ones to appeal to more GLP-1 users who may be looking for specific nutrition needs like high-protein, high-fiber foods. In that story, we mentioned one tiny but important research paper by Cornell University that showed that households with at least one GLP-1...

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot program that would touch hundreds of lives: It started covering obesity drugs for state employees—even as many other insurers balked at what they considered expensive “vanity” drugs. The program was, by health measures, a success. Patients shed as much as 120 pounds, their cholesterol dropped, their prediabetes faded, and they cut down on blood-pressure meds. As word began to spread, more patients wanted to join. A school nurse told me her weight loss inspired at least six other...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts energy use, and enhances insulin sensitivity without causing nausea or muscle loss. This discovery may pave the way for effective treatments for obesity and type 2 diabetes. Millions worldwide benefit from weight loss drugs derived from the incretin hormone GLP-1. These medications not only aid in weight management but also enhance kidney function, lower the risk of fatal cardiac events, and show potential in protecting against neurodegeneration. However, many individuals discontinue these medications due to common side effects such as nausea...

The round mound of rebound is less rotund. On an appearance on “The Pat McAfee Show” last week, Charles Barkley revealed that he is down over 60 pounds since he started taking the weight-loss drug Mounjaro. “I started taking this drug called Mounjaro about six months ago,” Barkley said. “It’s been amazing. My doctor, she is amazing. I know a lot of people take Ozempic, but my doctor prefers Mounjaro. I started at 352, and I’m down to 290. “It’s been great, I’ve been starting to feel like a human being — not a fat-ass anymore. I want to lose...

Popular celebrity weight-loss drugs Wegovy and Ozempic could have serious side effects, according to researchers in China. In a study set to appear in the monthly journal Acta Pharmaceutica Sinica B, researchers believe that there is an “increased risk” of intestinal obstruction when taking those medications. The drugs are made up of the peptide semaglutide, a derivative of GLP-1, a hormone derived from the small intestine.

This article was featured in One Great Story, New York’s reading recommendation newsletter. Sign up here to get it nightly. Allison is an actress. When we meet up for coffee — she has an almond-milk cortado — in midtown, something’s different about her, but I’m not sure what. She looks like an Instagram version of herself but in real life. It turns out she’s down about ten pounds and happy about it. “Somebody once told me I had a size-zero personality, and they assumed that I was thinner than I was,” she tells me. “We don’t talk about it, but...